Transverse Tibial Cortex Transport in the Treatment of Kawasaki Disease

Main Article Content

Alexandre Sacchetti Bezerra
https://orcid.org/0000-0001-6870-7465
João Kleber de Almeida Gentile
https://orcid.org/0000-0001-8650-2703
Fábio Lucas Rodrigues
João Antônio Corrêa
André Luiz Pereira Fornitano
Natália Rebeque Modolo
Fernando Luvizotto Carvalho
Cláudio Jun Shimizu

Abstract

Kawasaki disease is a systemic primary vasculitis of medium-sized vessels, predominantly affecting children, whose diagnosis and management in adulthood remain challenging, particularly in the presence of rare peripheral vascular manifestations. Severe ischemic limb lesions in adult patients with sequelae of the disease have limited therapeutic options, with amputation often being indicated. This study reports the first case described in the literature of the use of Transverse Tibial Cortex Transport (TTT) as a limb-salvage strategy in an adult patient with Kawasaki disease and critical lower limb ischemia. A 38-year-old female patient, with a history of spontaneous resolution of the disease in childhood, evolved with severe chronic ischemia, a trophic lesion with bone exposure, absence of a distal runoff bed, and failure of conventional clinical therapies. Given the impossibility of revascularization and a prior indication for amputation, TTT was performed. A significant clinical improvement in perfusion was observed, evidenced by increased ankle pressure, reduced capillary refill time, progressive wound healing, and recovery of functional ambulation. Follow-up computed tomography angiography demonstrated neovascularization and the development of collateral circulation previously absent. TTT proved to be a viable and effective alternative for limb preservation in this pioneering case of Kawasaki disease, suggesting potential application in other primary vasculitides associated with critical ischemia. Prospective studies are needed to better define its indications, pathophysiological mechanisms, and long-term outcomes.

Article Details

How to Cite
Bezerra, A. S., Gentile, J. K. de A., Rodrigues, F. L., Corrêa, J. A., Fornitano, A. L. P., Modolo, N. R., Carvalho, F. L., & Shimizu, C. J. (2026). Transverse Tibial Cortex Transport in the Treatment of Kawasaki Disease. Brazilian Journal of Case Reports, 6(1), bjcr158. https://doi.org/10.52600/2763-583X.bjcr.2026.6.1.bjcr158
Section
Clinical Case Reports
Author Biographies

Alexandre Sacchetti Bezerra, Emilio Ribas Institute of Infectious Diseases (IIER-SP)

Emilio Ribas Institute of Infectious Diseases (IIER-SP), São Paulo, Brazil.

João Kleber de Almeida Gentile, Emilio Ribas Institute of Infectious Diseases (IIER-SP)

Emilio Ribas Institute of Infectious Diseases (IIER-SP), São Paulo, Brazil.

Fábio Lucas Rodrigues, University Center of the ABC School of Medicine

University Center of the ABC School of Medicine, Santo André, São Paulo, Brazil.

João Antônio Corrêa, Santo André Municipal Hospital Center (CHMSA–SP)

Santo André Municipal Hospital Center (CHMSA–SP), Santo André, São Paulo, Brazil.

André Luiz Pereira Fornitano, Santo André Municipal Hospital Center (CHMSA–SP)

Santo André Municipal Hospital Center (CHMSA–SP), Santo André, São Paulo, Brazil.

Natália Rebeque Modolo, Hospital das Clínicas of São Bernardo do Campo

Hospital das Clínicas of São Bernardo do Campo, São Bernardo do Campo, São Paulo, Brazil.

Fernando Luvizotto Carvalho, University Center of the ABC School of Medicine

University Center of the ABC School of Medicine, Santo André, São Paulo, Brazil.

Cláudio Jun Shimizu, Hospital das Clínicas of São Bernardo do Campo

Hospital das Clínicas of São Bernardo do Campo, São Bernardo do Campo, São Paulo, Brazil.

References

Gorelik M, Chung SA, Smith RM, et al. 2021 American College of Rheumatology/Vasculitis Foundation guideline for the management of Kawasaki disease. Arthritis Care Res (Hoboken). 2022;74(4):538-548. doi:10.1002/acr.24838.

Martins-Martinho J, Saldanha J, Canhão H. Localized forms of vasculitis. Curr Rheumatol Rep. 2021;23(7):49. doi:10.1007/s11926-021-01012-y.

Bezerra AS, Brito CJ, Guedes-Neto HJ, et al. Algorithm for diagnosis of primary vasculitides. J Vasc Bras. 2019;18:e20180092. doi:10.1590/1677-5449.009218.

Shono M, Okubo Y, Hashimoto K, et al. The clinical characteristics of Kawasaki disease patients with sterile pyuria. Pediatr Infect Dis J. 2026;45(1):36-39. doi:10.1097/INF.0000000000004988.

Rife E, Gedalia A. Kawasaki disease: an update. Curr Rheumatol Rep. 2020;22(10):75. doi:10.1007/s11926-020-00941-4.

Uehara R, Belay ED, Maddox RA, et al. Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan. Pediatr Infect Dis J. 2008;27(2):155-160. doi:10.1097/INF.0b013e31815922b5.

Chakraborty S, Sengupta D, Rahaman M, Dey P, Moitra S, Sen D. Multisystemic adverse reactions to amlodipine mimicking vasculitis. Braz J Case Rep. 2025;6(1):bjcr127. doi:10.52600/2763-583X.bjcr.2026.6.1.bjcr127.

Bezerra AS, Guedes-Neto HJ, Brito CJ, et al. Early diagnosis and treatment of leukocytoclastic vasculitis: case report. J Vasc Bras. 2020;19:e20180072. doi:10.1590/1677-5449.190072.

Almasoudi AA, Alharbi NS, Alqahtani AA, et al. Ceftriaxone-induced leukocytoclastic vasculitis: a case report and litera-ture review of antibiotic-induced leukocytoclastic vasculitis. J Int Med Res. 2022;50(5):3000605221097768. doi:10.1177/03000605221097768.

Parra RS, Lopes A, Figueiredo MN, et al. Leukocytoclastic vasculitis secondary to anti-tumor necrosis factor therapy in in-flammatory bowel diseases: a multicenter retrospective cohort study. J Clin Med. 2023;12(9):3165. doi:10.3390/jcm12093165.

Dionne A, Baker AL, Son MBF, et al. Treatment intensification in patients with Kawasaki disease and coronary aneurysm at diagnosis. Pediatrics. 2019;143(6):e20183341. doi:10.1542/peds.2018-3341.

Tomita S, Suganuma E, Hoshino S, et al. Peripheral gangrene associated with Kawasaki disease. Clin Infect Dis. 1992;14(1):121-126. doi:10.1093/clinids/14.1.121.

Liu Z, Liu J, Zhou Y, et al. Twenty years development of tibial cortex transverse transport surgery in PR China. Orthop Surg. 2022;14(6):1034-1048. doi:10.1111/os.13214.

Yang Y, Liu Z, Li J, et al. Tibial cortex transverse transport accelerates wound healing via enhanced angiogenesis and im-munomodulation. Bone Joint Res. 2022;11(4):189-199. doi:10.1302/2046-3758.114.BJR-2021-0364.R1.

Fan ZQ, Liu ZJ, Li J, et al. Tibial cortex transverse distraction in treating diabetic foot ulcers: what are we concerned about? J Int Med Res. 2020;48(9):300060520954697. doi:10.1177/0300060520954697.

Caraballo C, Desai NR, Mulder H, et al. Clinical implications of the New York Heart Association classification. J Am Heart Assoc. 2019;8(23):e014240. doi:10.1161/JAHA.119.014240.

Bezerra AS, Guedes-Neto HJ, Brito CJ, et al. Herpes zoster and polyarteritis nodosa: diagnostic challenges. Infectol Evid. 2022;1(1). doi:10.5935/2764-734X.e202112004.

Wu Y, Li J, Liu X, et al. Different dose aspirin plus immunoglobulin (DAPI) for prevention of coronary artery abnormalities in Kawasaki disease: study protocol for a multicenter, prospective, randomized, open-label, blinded end-point, non-inferiority trial. Am Heart J. 2024;273:1-9. doi:10.1016/j.ahj.2024.03.010.

Cerqueira LDO, Bezerra AS, Brito CJ, et al. WIfI classification: the Society for Vascular Surgery lower extremity threatened limb classification system, a literature review. J Vasc Bras. 2020;19:e20190070. doi:10.1590/1677-5449.190070.

Mills JL Jr. Update and validation of the Society for Vascular Surgery wound, ischemia, and foot infection threatened limb classification system. Semin Vasc Surg. 2014;27(1):16-22. doi:10.1053/j.semvascsurg.2014.12.002.

Most read articles by the same author(s)